apretude

Generic: cabotegravir

Labeler: viiv healthcare company
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name apretude
Generic Name cabotegravir
Labeler viiv healthcare company
Dosage Form KIT
Manufacturer
ViiV Healthcare Company

Identifiers & Regulatory

Product NDC 49702-264
Product ID 49702-264_cedc4b34-5c83-4d5f-a47f-7d5e93f71459
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA215499
Listing Expiration 2026-12-31
Marketing Start 2021-12-20

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 49702264
Hyphenated Format 49702-264

Supplemental Identifiers

RxCUI
2588077 2588080

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name apretude (source: ndc)
Generic Name cabotegravir (source: ndc)
Application Number NDA215499 (source: ndc)

Resolved Composition

Strengths
  • 600 mg/3 ml
  • 200 mg/ml
source: label
Packaging
  • 1 KIT in 1 CARTON (49702-264-23) * 3 mL in 1 VIAL (49702-238-03)
source: ndc

Packages (1)

49702-264-23 1 KIT in 1 CARTON (49702-264-23) * 3 mL in 1 VIAL (49702-238-03)

Ingredients (0)

No ingredient records.

Linked Drug Pages (1)

Apretude ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"spl_id": "cedc4b34-5c83-4d5f-a47f-7d5e93f71459", "openfda": {"rxcui": ["2588077", "2588080"], "spl_set_id": ["4338428e-43d4-4e02-ac9d-bd98e738a7da"], "manufacturer_name": ["ViiV Healthcare Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 KIT in 1 CARTON (49702-264-23)  *  3 mL in 1 VIAL (49702-238-03)", "package_ndc": "49702-264-23", "marketing_start_date": "20211220"}], "brand_name": "Apretude", "product_id": "49702-264_cedc4b34-5c83-4d5f-a47f-7d5e93f71459", "dosage_form": "KIT", "product_ndc": "49702-264", "generic_name": "Cabotegravir", "labeler_name": "ViiV Healthcare Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Apretude", "application_number": "NDA215499", "marketing_category": "NDA", "marketing_start_date": "20211220", "listing_expiration_date": "20261231"}